1. Home
  2. AVDL vs AIOT Comparison

AVDL vs AIOT Comparison

Compare AVDL & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • AIOT
  • Stock Information
  • Founded
  • AVDL 2015
  • AIOT 1993
  • Country
  • AVDL Ireland
  • AIOT United States
  • Employees
  • AVDL N/A
  • AIOT N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • AVDL Health Care
  • AIOT Telecommunications
  • Exchange
  • AVDL Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • AVDL 784.6M
  • AIOT 787.1M
  • IPO Year
  • AVDL 1996
  • AIOT N/A
  • Fundamental
  • Price
  • AVDL $9.11
  • AIOT $4.55
  • Analyst Decision
  • AVDL Strong Buy
  • AIOT Strong Buy
  • Analyst Count
  • AVDL 6
  • AIOT 4
  • Target Price
  • AVDL $18.17
  • AIOT $10.50
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • AIOT 2.1M
  • Earning Date
  • AVDL 05-07-2025
  • AIOT 06-16-2025
  • Dividend Yield
  • AVDL N/A
  • AIOT N/A
  • EPS Growth
  • AVDL N/A
  • AIOT N/A
  • EPS
  • AVDL N/A
  • AIOT N/A
  • Revenue
  • AVDL $194,450,000.00
  • AIOT $292,953,000.00
  • Revenue This Year
  • AVDL $55.11
  • AIOT $174.10
  • Revenue Next Year
  • AVDL $30.13
  • AIOT $22.01
  • P/E Ratio
  • AVDL N/A
  • AIOT N/A
  • Revenue Growth
  • AVDL 252.64
  • AIOT 119.05
  • 52 Week Low
  • AVDL $6.38
  • AIOT $3.70
  • 52 Week High
  • AVDL $17.30
  • AIOT $8.71
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 53.96
  • AIOT 34.64
  • Support Level
  • AVDL $8.77
  • AIOT $4.55
  • Resistance Level
  • AVDL $9.31
  • AIOT $6.05
  • Average True Range (ATR)
  • AVDL 0.41
  • AIOT 0.27
  • MACD
  • AVDL -0.04
  • AIOT -0.14
  • Stochastic Oscillator
  • AVDL 53.60
  • AIOT 5.88

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: